About 1 result found for searched term "Budigalimab" (0.131 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24916 | Budigalimab | PD-1/PD-L1 |
| ABBV 181; PR 1648817 | ||
| Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
